Results 161 to 170 of about 70,698 (266)

Dysregulated TIE‐2 expression is associated with blood‐brain barrier leakiness and Alzheimer's disease‐related neuropathology

Brain Pathology, Volume 36, Issue 6, November 2026.
Ince et al., have analysed TIE‐1 and ‐2 expression in human brain tissue, including microvessel‐enriched fractions (MVF) and covering a spectrum of AD‐associated pathology, and in CSF from independent cohorts spanning a clinical spectrum from normal cognition to AD.
Selvi Ince, Carol Van Hulle, Gwendlyn Kollmorgen, Clara Quijano‐Rubio, Carey Gleason, Barbara B. Bendlin, Ozioma Okonkwo, Sanjay Asthana, Kaj Blennow, Henrik Zetterberg, Sterling C. Johnson, Seth Love, J. Scott Miners   +12 more
wiley   +1 more source

Correction: Oncobiotics in urinary bladder cancer. A narrative review of living cancer therapeutics. [PDF]

Front Oncol
Frontiers Production Office.
europepmc   +1 more source

Increased Expression of Desmin and Vimentin Impairs Mitochondrial Function and Reduces Contractility via G0S2 in Bladder Smooth Muscle

The FASEB Journal, Volume 40, Issue 20, 31 October 2026.
Our previous study demonstrated that elevated levels of desmin and vimentin reduce BSM contractility. This study shows that the reduced BSM contractility is associated with mitochondrial impairment. G0/G1 switch gene 2 (G0S2) is upregulated in desmin‐ and vimentin‐overexpressing BSM.
Elham Javed, Chellappagounder Thangavel, Karthik Thangavel, Joseph Hypolite, Isabelle Gamache, Yilin Wang, Sankar Addya, Darin Mak, Furqan Syed, Jyotsna Mishra, Vilas Desai, Pragnya Das, Dominic R. Villalba, Alok Bhushan, Shey‐Shing Sheu, Sunday A. Shoyele, Erin L. Seifert, Jose G. Teodoro, Steven S. An, Raymond B. Penn, Deepak A. Deshpande, Ettickan Boopathi   +21 more
wiley   +1 more source

Genotyping and Clinical Manifestations of Adenoviral Keratoconjunctivitis in South Korea. [PDF]

Korean J Ophthalmol
Park MJ, Lee SK, Kim HS, Seo JW.
europepmc   +1 more source

Integration of a multimeric STAT consensus site into the adenoviral genome to interfere with IFN signaling represents a novel concept to improve oncolytic virotherapy. [PDF]

J Virol
Wang D, Nassua S, Mantwill K, Zhao Y, Bambach JC, Gschwend JE, Holm PS, Nawroth R.   +7 more
europepmc   +1 more source

Genetic Medicine Approaches for Tumor Suppressor Loss: Therapeutic Replacement with Self-Amplifying RNA. [PDF]

Pharm Res
Mutha D, Vedula CP, Bhagavatula S, Grinstaff MW, Wong WW, Lu D, Ganem NJ, Flynn RL.   +7 more
europepmc   +1 more source

Recombinant adenoviruses application for cancer vaccines: from genetic design to clinical translation. [PDF]

Front Oncol
Almarghalani NA, Ganash MA, Alharbi MG, Abualfaraj T, Alkayyal AA, Mahmoud AB.   +5 more
europepmc   +1 more source

Clinical profile and risk factors of severe adenoviral infections among hospitalised children in South India: a cross-sectional study. [PDF]

BMJ Paediatr Open
Abraham S, John JJ, Johnson JJ, David A, Rajeshkumar N, Robert D.   +5 more
europepmc   +1 more source

Completed clinical trials of p53-targeted therapeutic strategies in cancer: A cross-sectional ClinicalTrials.gov registry analysis. [PDF]

Medicine (Baltimore)
Alorfi NM, Alourfi NM.
europepmc   +1 more source

Enhanced Immunogenicity and Cross-Neutralizing Activity of a Trivalent Adenoviral Vector-Based SARS-CoV-2 Vaccine in Mice. [PDF]

J Med Virol
Li J, Song W, Li J, Peng R, Chen C, Zhang Y, Zhu Y, Chen K.   +7 more
europepmc   +1 more source